Biosite
This article was originally published in The Gray Sheet
Executive Summary
Former Guidant Japanese vascular intervention division director Gary King is named VP-worldwide marketing on Aug. 19. King is credited with establishing a sales organization in Japan and increasing revenues by more than $80 mil. while at Guidant. Most recently, he served as Advanced Respiratory, Inc.'s national sales director...You may also be interested in...
Data For Two HER2-Positive Breast Cancer Drugs Impress, Including On Overall Survival
AstraZeneca/Daiichi Sankyo and Seattle Genetics presented exciting data at SABCS on drugs that extended survival in patients who had exhausted most treatment options.
The FDA Builds On Lessons Learned In Rebuilding Quality Metrics Program
US FDA officials tell industry that implementing a quality metrics program is an agency priority and that a rejiggered program will incorporate various elements of other quality metrics initiatives being piloted by the agency, industry and academia.
Sanofi Counts On OTC Switches Adding $1bn In Consumer Revenues By 2026
Sanofi eyes $1bn top line growth from OTC switches of ED drug Cialis and flu drug Tamiflu after they launch by 2026, says CEO Paul Hudson. Like switch consultants, though, he acknowledges the high bar for approval moving additional Rx ingredients to OTC.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: